TSBXTurnstone Biologics Corp.

Nasdaq turnstonebio.com


$ 2.84 $ -0.38 (-11.69 %)    

Thursday, 09-May-2024 15:59:55 EDT
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 2.87
$ 3.18
$ 0.00 x 0
$ 0.00 x 0
$ 2.84 - $ 3.20
$ 1.63 - $ 13.20
143,089
na
33.19M
$ 6.93
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-22-2024 12-31-2023 10-K
2 11-10-2023 09-30-2023 10-Q
3 09-01-2023 06-30-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 turnstone-biologics-q4-eps-073-beats-086-estimate

Turnstone Biologics (NASDAQ:TSBX) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of $...

 turnstone-biologics-q3-eps-100-up-from-615-yoy-cash-cash-equivalents-and-short-term-investments-1091m

Turnstone Biologics (NASDAQ:TSBX) reported quarterly losses of $(1.00) per share. This is a 83.74 percent increase over losses ...

 why-parazero-technologies-shares-are-trading-higher-by-over-100-here-are-other-stocks-moving-in-mondays-mid-day-session

Gainers ParaZero Technologies Ltd. (NASDAQ: PRZO) shares jumped 106% to $2.3901 after the company announced an Australian re...

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 311 stocks hit new 52-week lows.

 stocks-that-hit-52-week-lows-on-thursday

  During the session on Thursday, 461 stocks hit new 52-week lows.

 top-4-health-care-stocks-that-could-lead-to-your-biggest-gains-in-q3

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

 b-of-a-securities-initiates-coverage-on-turnstone-biologics-with-buy-rating-announces-price-target-of-18

B of A Securities analyst Geoff Meacham initiates coverage on Turnstone Biologics (NASDAQ:TSBX) with a Buy rating and announ...

 piper-sandler-initiates-coverage-on-turnstone-biologics-with-overweight-rating-announces-price-target-of-20

Piper Sandler analyst Joseph Catanzaro initiates coverage on Turnstone Biologics (NASDAQ:TSBX) with a Overweight rating and ...

 turnstone-biologics-corp-announces-pricing-of-80m-upsized-initial-public-offering-of-666m-shares-of-common-stock-at-a-price-of-12share-shares-to-open-for-trade-today

Turnstone Biologics Corp. ("Turnstone" or the "Company") (NASDAQ:TSBX), a clinical-stage biotechnology company ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION